Medline's growth continues as it breaks ground on 1.2 million sq. ft distribution center in Midlothian, Texas
Rhea-AI Summary
Medline (Nasdaq: MDLN) broke ground on a new 1.2 million sq. ft. distribution center in Midlothian, Texas, expanding its U.S. network of 45 distribution centers. The facility is expected to be fully operational in Q2 2027 and will include advanced automation such as AutoStore.
The site is Medline's second in the Dallas–Fort Worth area, supports next-day delivery to 95% of U.S. customers, and follows the company’s December 2025 initial public offering.
Positive
- Constructing a 1.2 million sq. ft. distribution center in Midlothian, Texas
- Expansion increases national DC network beyond 45 centers, strengthening distribution footprint
- New DC expected to be fully operational in Q2 2027, adding regional capacity in Dallas–Fort Worth
- Facility will deploy advanced automation including AutoStore, aligning with other large distribution centers
- Next-day delivery to 95% of U.S. customers supported by expanded network and owned fleet
Negative
- None.
News Market Reaction – MDLN
In the Mar 11 session, MDLN declined 1.14%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 10 | Secondary offering close | Neutral | -1.2% | Closing of secondary offering by selling holders at $41.00 per share. |
| Mar 09 | Operations awards news | Positive | -1.0% | Recognition of top-performing distribution centers and safety-focused SAFE awards. |
| Mar 04 | Secondary offering pricing | Neutral | +2.7% | Pricing of 75,000,000 Class A shares at $41.00 by selling holders. |
| Mar 03 | Secondary offering launch | Neutral | -3.2% | Launch of underwritten offering of 75,000,000 Class A shares by sponsors. |
| Feb 25 | Earnings results | Positive | -3.6% | Strong FY2025 sales growth with guidance for 2026 organic sales and EBITDA. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent history shows negative reactions to positive corporate updates (awards, earnings) and mixed responses around secondary offerings by selling shareholders.
Over the last few weeks, Medline reported strong FY2025 results on Feb 25, including full-year net sales of $28.4B and Adjusted EBITDA of $3.5B, yet the stock fell 3.62%. A secondary offering by selling stockholders was launched, priced and then closed between Mar 3–10, with mixed price moves from -3.18% to +2.73%. The latest announcement of a new 1.2M sq. ft Texas distribution center continues the growth and logistics build-out highlighted throughout these updates.
Key Terms
class a common stock financial
class b common stock financial
form 4 regulatory
form 3 regulatory
restricted stock unit financial
common units financial
incentive units financial
initial public offering financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Groundbreaking is first operational initiative as a publicly traded company on its continued trajectory of growth
This second distribution center in the
"Today we have more than 26 million square feet of warehouse space in the
The
"Our network of distribution centers strategically located across the country enables us to provide next-day delivery to
About Medline
Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its unique offering of world-class products, supply chain resilience and clinical practice expertise, Medline delivers improved clinical, financial and operational outcomes. Headquartered in
Contact:
Carroll Henning
(847) 226-0587
chenning@medline.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/medlines-growth-continues-as-it-breaks-ground-on-1-2-million-sq-ft-distribution-center-in-midlothian-texas-302711339.html
SOURCE Medline